Seroquel in a resistant schizophrenic with negative and positive symptoms

I. Reznik, R. Benatov, P. Sirota

Research output: Contribution to journalArticlepeer-review


Refractoriness to treatment is a common problem in management of schizophrenics. Conventional pharmacotherapy is usually effective in controlling positive symptoms of the disease, such as delusions and hallucinations. However, they have restricted ability to affect negative symptoms (flat affect, social withdrawal) and to reverse functional disability and behavioral deviance. Furthermore, typical neuroleptics produce adverse effects, such as extrapyramidal symptoms and tardive dyskinesia. A new generation of antipsychotic agents with a low profile of side-effects and good tolerance has recently been developed and actively investigated. Seroquel (ICI 204-636), a dibenzoth azepine derivative, is a novel, putative, potential, atypical neuroleptic; it is a combined dopamine/ serotonin receptor antagonist. We report a 54-year-old man suffering from chronic therapy-resistant schizophrenia, with both positive and negative symptoms, who was successfully treated with Seroquel during 1 year.

Original languageEnglish
Pages (from-to)675-677, 727
Issue number10
StatePublished - 15 May 1996
Externally publishedYes


Dive into the research topics of 'Seroquel in a resistant schizophrenic with negative and positive symptoms'. Together they form a unique fingerprint.

Cite this